WO1999058727A1 - Viral characterization by direct detection of capsid proteins - Google Patents

Viral characterization by direct detection of capsid proteins Download PDF

Info

Publication number
WO1999058727A1
WO1999058727A1 PCT/US1999/010658 US9910658W WO9958727A1 WO 1999058727 A1 WO1999058727 A1 WO 1999058727A1 US 9910658 W US9910658 W US 9910658W WO 9958727 A1 WO9958727 A1 WO 9958727A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
mass spectrometry
proteins
matrix
viral
Prior art date
Application number
PCT/US1999/010658
Other languages
French (fr)
Inventor
John J. Thomas
Catherine Fenselau
Original Assignee
University Of Maryland At Baltimore County
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Maryland At Baltimore County filed Critical University Of Maryland At Baltimore County
Priority to AU39907/99A priority Critical patent/AU3990799A/en
Publication of WO1999058727A1 publication Critical patent/WO1999058727A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • G01N33/6851Methods of protein analysis involving laser desorption ionisation mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses

Definitions

  • MALDI mass spectrometry
  • Mass spectrometry also provides mass measurements in a
  • Viruses and bacteriophages contain large quantities of
  • nucleocapsid or coat protein encapsulates nucleic acid molecules a t
  • protein capsid layer is surrounded by a lipoglycoprotein layer.
  • viruses in this study consist of a defined number of homogeneous viruses
  • capsid protein molecules in close association with the viral nucleic
  • Figure 1 displays the structures of the MS2, tobacco mosaic
  • TMV Venezuelan equine encephalitis
  • VEE Venezuelan equine encephalitis
  • TMV and the MS2 bacteriophage are representative of a n
  • MS2 bacteriophage consist of 180 copies of a coat protein with a
  • the TMV virus is a spherical virus consisting solely of coat proteins, which has species
  • encephalitis contains a single stranded RNA genome encapsulated b y
  • MALDI Matrix-assisted laser desorption ionization
  • the organic acid is acetic acid
  • a representative viral protein is a capsid protein.
  • purified or non-purified sample is prepared from the complex
  • the method detects
  • the method also detects bacteriophage proteins.
  • Figure 1 shows the structure of bacteriophage and virus .
  • Figure 1 A shows MS2 bacteriophage
  • Figure IB shows tobacco
  • Figure IC shows Venezuelan equine encephalitis
  • Figure 2 shows the matrix-assisted laser desorption
  • Figure 3 shows the matrix-assisted laser desorption
  • Figure 4 shows the matrix-assisted laser desorption
  • FIG. 5 shows MALDI mass spectrum of sucrose
  • viral proteins from a complex medium comprising th e
  • steps of preparing a crude sample of the medium mixing the sample
  • sample refers to the unadulterated growth medium which ma y
  • the organic acid is any organic acid known in the art based on the disclosure herein.
  • the organic acid is
  • the crude sample is either semi-purified or non-purified preparation and may contain only femtomolar levels of viral proteins .
  • the viral protein is a capsid protein.
  • the method may also detect bacteriophage proteins.
  • Bacteriophage stock suspension was added to the bacterial culture
  • the phage culture was incubated at 37°C for 2-3 hours.
  • VEE-TRD VEE-TRD 3000 strain was expressed from cDNA, and propagated in
  • the growth media was composed of
  • the semi-purified virus was irradiated with Co 60 for
  • bovine serum albumin (M.W. 66,431) for MS2, TMV, and VEE-TRD
  • hydrophobic regions contribute to the nucleocapsid or coat structure .
  • virus sample and matrix alone alone.
  • optimal broth contains large quantities of salts, peptides, and proteins ,
  • phage culture had an active concentration of 2.1 x l 0 10 pfu/ml, which
  • Citric acid yielded better mas s
  • Citric acid has three acidic
  • protons one with a pKa lower than the single acidic proton of acetic
  • citrate has been shown to enhance MALDI protein spectra from
  • the extract provided more intense (i.e. as much as lOx ion
  • Figure 5 displays the mass spectrum of the nucleocapsid
  • the present invention demonstrates that UV-MALDI can
  • additives increase the probability of observing viral proteins ;

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

The present invention provides a method of direct detecting of capsid proteins from intact viral particles using matrix-assisted laser desorption/ionization (MALDI) time-of-flight mass spectrometry, which enables viral proteins to be characterized at the femtomolar level in complex biological milieu with minimal or no cleanup.

Description

VIRAL CHARACTERIZATION BY DIRECT DETECTION
OF CAPSID PROTEINS
BACKGROUND OF THE INVENTION
Cross Reference to Related Applications
This application claims benefit of non-provisional
application US Serial number 09/120,861 , filed July 22, 1998, which
claims benefit of provisional application US Serial number
60/085,389, filed May 14, 1998, now abandoned.
Field of the Invention
The present invention relates generally to the fields of
analytical chemistry and biochemistry. More specifically, the present
invention relates to direct viral characterization by mas s
spectrometric detection of capsid proteins. Description of the Related Art
Medical, agricultural, and military personnel who need to
monitor and identify microbial agents often utilize enzyme-linked
immunosorbent assays, serological, morphological, and other
microbiological methods (1). Certain viruses represent a biological
threat; therefore, a need exists for rapid detection of characteristic
viral biomarkers. Field responses to biological agents require
completion of the entire analysis in less than 10 minutes, thereby
leaving only minutes for chemical manipulation of the sample.
Since the inception of matrix-assisted laser desorption
ionization (MALDI) mass spectrometry (2), the marriage of this
desorption/ionization technique with time-of-flight mass
spectrometers has enabled scientists to detect large biopolymers with
high sensitivity (3). Semi-purified mixtures of proteins have bee n
analyzed with matrix-assisted laser desorption ionization mas s
spectrometry in the past, thereby providing a more accurate
alternative to the commonly used SDS/PAGE analysis of protein
mixtures (4). The energy imparted from matrix-assisted laser
desorption ionization onto proteins and the conformationally
indiscriminate time-of-flight removes some effects of complex protein
solution behavior, which can alter the gel migration of different proteins. Mass spectrometry also provides mass measurements in a
shorter amount of time than electrophoresis.
Viruses and bacteriophages contain large quantities of
proteins, which perform various functions for each virion. One type
of protein commonly found in viruses, which is known as a
nucleocapsid or coat protein, encapsulates nucleic acid molecules a t
the core of the organism. In certain more complex virions, this
protein capsid layer is surrounded by a lipoglycoprotein layer. The
viruses in this study consist of a defined number of homogeneous
capsid protein molecules in close association with the viral nucleic
acids. Figure 1 displays the structures of the MS2, tobacco mosaic
(TMV) and Venezuelan equine encephalitis (VEE) viruses.
TMV and the MS2 bacteriophage are representative of a n
RNA virus and bacteriophage respectively. Despite different protein
conformations and resulting structural organization, these proteins
perform similar functions of acting as translational repressors of th e
phage-encoded replicase gene, protecting the viral RNA, and serving
as a nucleation site for viral assembly. The icosadeltahedron shaped
MS2 bacteriophage consist of 180 copies of a coat protein with a
molecular weight of 13,730 Da surrounding a single stranded RNA,
and one copy of an "A-protein" (MW -44 kDa). The TMV virus is a spherical virus consisting solely of coat proteins, which has species
dependent molecular weights of 17,100-17,600 Da.
Venezuelan equine encephalitis was used as an example of
membrane-containing viruses, which are assembled by interaction of
viral proteins with the host cell membrane. Venezuelan equine
encephalitis contains a single stranded RNA genome encapsulated b y
240 copies of a nucleocapsid protein (M.W. 30,940 Da) surrounded b y
a lipid bilayer containing two glycoproteins, El and E2 that have
molecular masses of -50,000 and -56,000 Da, respectively (5 -7).
While the relative abundance of these unique biomarkers presents a n
opportunity for identification of the virus, scientists have only
recently attempted to rapidly identify these biomarkers. Previously ,
mass spectrometric detection of viral coat proteins required extensive
off-line or elaborate on-line cleanup processes. Despeyroux et al.
utilized HPLC on-line with electrospray mass spectrometry to
determine molecular weights of specific capsid proteins (8).
The prior art is deficient in the lack of effective means of
identifying viruses from completely crude biological media with
minimal or no cleanup. Further, the prior art is deficient in the lack
of effective means for rapid detection of as little as femtomoles of coat protein within a complex biological medium. The present
invention fulfills this long-standing need and desire in the art.
SUMMARY OF THE INVENTION
Matrix-assisted laser desorption ionization (MALDI) mas s
spectrometry has enabled detection of viral proteins with minimal
separation from crude biological media. This analysis has been
achieved with a combination of organic acids and high energy
desorption with a nitrogen laser. The molecular weights from these
proteins are sufficiently unique to differentiate among species of
viruses in a variety of biological conditions. This analysis has
provided the means for rapid detection of as little as femtomoles of
coat protein within a complex biological medium.
In one embodiment of the present invention, there is
provided a method of detecting viral structural proteins rapidly an d
directly from a complex environment by utilizing mass spectrometry
with the addition of specific organic acids.
In a preferred embodiment, the organic acid is acetic acid
or citric acid, and premixed with mass spectrometry matrix. A representative viral protein is a capsid protein. Preferably, the semi-
purified or non-purified sample is prepared from the complex
environment.
Representative examples of mass spectrometry are fast
atom bombardment, mass spectrometry, plasma desorption mas s
spectrometry, laser desorption mass spectrometry, matrix- assisted
laser desorption ionization time-of-flight mass spectrometry a n d
electrospray mass spectrometry, wherein the laser is of any kind an d
has wavelength of any range. Preferably, the method detects
femtomolar concentration of the viral protein in less than 3 minutes .
The method also detects bacteriophage proteins.
Other and further aspects, features, and advantages of th e
present invention will be apparent from the following description of
the presently preferred embodiments of the invention given for the
purpose of disclosure.
BRIEF DESCRIPTION OF THE DRAWINGS
So that the matter in which the above-recited features ,
advantages and objects of the invention, as well as others which will become clear, are attained and can be understood in detail, more
particular descriptions of the invention briefly summarized above
may be had by reference to certain embodiments thereof which are
illustrated in the appended drawings. These drawings form a part of
the specification. It is to be noted, however, that the appended
drawings illustrate preferred embodiments of the invention an d
therefore are not to be considered limiting in their scope.
Figure 1 shows the structure of bacteriophage and virus .
Figure 1 A shows MS2 bacteriophage, Figure IB shows tobacco
mosaic virus, and Figure IC shows Venezuelan equine encephalitis
virus.
Figure 2 shows the matrix-assisted laser desorption
ionization mass spectra of semi-purified MS2 bacteriophage with
acetic acid (Figure 2A), and citric acid (Figure 2B ) with α-cyano-4-
hydroxycinnamic acid matrix .
Figure 3 shows the matrix-assisted laser desorption
ionization mass spectrum of MS2 bacteriophage from crude culture
broth with acetic acid and α-cyano-4-hydroxycinnamic acid matrix.
Figure 4 shows the matrix-assisted laser desorption
ionization mass spectrum of tobacco mosaic virus directly from a piece of an infected leaf. 2M citric acid and sinapinic acid matrix
were applied to the infected leaf piece prior to desorption.
Figure 5 shows MALDI mass spectrum of sucrose
gradient purified Venezuelan equine encephalitis with acetic acid an d
sinapinic acid matrix.
DETAILED DESCRIPTION OF THE INVENTION
In the present invention, a method of rapid detecting of
viral proteins from a complex medium is disclosed, comprising th e
steps of preparing a crude sample of the medium; mixing the sample
with an organic acid; and detecting viral characteristic structural
proteins by utilizing mass spectrometry. As used herein, "crude
sample" refers to the unadulterated growth medium which ma y
contain salts, buffers, peptides, lipids, oligonucleotides, sugars an d
other chemicals. Certain organic acids will be useful in this technique
as will be readily recognized by a person having ordinary skill in this
art based on the disclosure herein. Preferably, the organic acid is
acetic acid or citric acid, and premixed with mass spectrometry
matrix. The crude sample is either semi-purified or non-purified preparation and may contain only femtomolar levels of viral proteins .
In a preferred embodiment, the viral protein is a capsid protein.
Representative examples of mass spectrometry are fast atom
bombardment mass spectrometry, plasma desorption mas s
spectrometry, laser desorption mass spectrometry, matrix-assisted
laser desorption ionization time-of-flight mass spectrometry an d
electrospray mass spectrometry, wherein the laser is of any kind an d
has wavelength of any range. In a preferred embodiment, th e
method detects femtomolar concentration of the viral protein in less
than 3 minutes. The method may also detect bacteriophage proteins.
The following examples are given for the purpose of
illustrating various embodiments of the invention and are not me ant
to limit the present invention in any fashion.
EXAMPLE 1
Equipment and Chemicals
MALDI spectra were taken on a Kratos/Shimadzu Kompact
MALDI III ™ (Manchester, U. K.) in linear mode. Matrix-assisted laser
desorption ionization was attained with a nitrogen laser (λ = 337 nm)
and an acceleration voltage of 20 kV. Samples were desorbed from stainless steel plates with preconstructed sample wells. All protein
standards and matrices were purchased from Sigma Chemical Co. (St.
Louis, Mo) and used as received. HPLC-grade solvents were
purchased from Fisher Scientific, Inc. (Pittsburgh, PA).
EXAMPLE 2
Biological Growth Conditions
A host culture of an Hfr strain (i.e. male specific) of E. Coli
(ATCC 15669; Rockville, MD) was grown for 16 hours at 37°C in MS2
broth, and was then used to inoculate a larger culture (9).
Bacteriophage stock suspension was added to the bacterial culture
when the culture reached 108 cfu/ml as determined with a Gilford
RESPONSE™ dual channel UV-spectrophotometer (Gilford Instruments ;
Oberlin, OH). The phage culture was incubated at 37°C for 2-3 hours.
Homogenates of ground tobacco leaf samples (ATCC PV-
635) in 50 mM phosphate buffer (pH 7.5) were used to propagate
tobacco mild green mosaic virus (U2 strain) onto healthy young
tobacco plants. The plants were inoculated by causing microscopic
abrasions with a throat-powder spray of carborundum before applying the sap homogenate by hand (10). The infected plants were
sustained under incandescent/UV light for 2 weeks before harvest.
All materials in contact with TMV were sterilized after use.
Venezuelan equine encephalitis Trinidad donkey virus
(VEE-TRD) 3000 strain was expressed from cDNA, and propagated in
baby hamster kidney cells. The growth media was composed of
EMEM supplemented with 5% fetal bovine serum. The collected virus
was precipitated with polyethylene glycol and salt. The precipitate
was resuspended in phosphate buffer saline and layered onto a
sucrose gradient. The semi-purified virus was irradiated with Co60 for
safe handling.
EXAMPLE 3
Analytical Methods
Crude MS2, as well as VEE preparations with 50% ( v/v )
organic acid were applied directly to the stainless steel MALDI slide
with a small volume metal tip syringe, and sandwiched by the matrix
(11). Crude TMV samples were analyzed by cleanly cutting strips of
infected leaves, and strategically placing them on stainless steel slides with one-sided tape. The leaf slices were treated with 0.3 μl of
organic acid 15-30 seconds before adding 2 x 0.3 μl of matrix. Semi-
purified preparations of MS2/E. Coli and TMV were processed b y
pelleting bacteria and plant cell debris with high speed centrifugation ,
and the supernatant containing the virus was partially purified b y
centrifugation-filtration (Ultrafree filters, Millipore Corp., Bedford,
MA).
External calibrations were executed with chicken
lysozyme (M.W. 14,307), bovine trypsinogen (M.W. 23,957), a n d
bovine serum albumin (M.W. 66,431) for MS2, TMV, and VEE-TRD
analysis, respectively. In order to avoid spatial source effects,
calibration for crude TMV analysis was performed by applying th e
calibrant and matrix to a separate piece of tobacco leaf.
EXAMPLE 4
Results
Detection, mass accuracy, and mass resolution of viral
proteins with matrix-assisted laser desorption ionization are
dependent on sample preparation and complexity, as well as mas s spectrometric conditions. Capsid proteins often contain hydrophobic
regions that maintain the protein-protein associations. These
hydrophobic regions contribute to the nucleocapsid or coat structure ,
and cause aggregation in aqueous solution. Despite a high percentage
of organic content in the matrix solvent, no signal was observed from
virus sample and matrix alone.
EXAMPLE 5
Detection of MS2 Bacteriophage
The growth conditions for MS2 yield numerous amounts of
biomolecules released from lysed host bacterial cells. In addition, th e
optimal broth contains large quantities of salts, peptides, and proteins ,
which potentially suppress the signal of interest in the matrix -
assisted laser desorption ionization spectrum. Considering the MS 2
phage culture had an active concentration of 2.1 x l 010 pfu/ml, which
translates to a minimum 1 femtomole of coat protein applied to th e
slide well, any signal suppression could lead to no observed peak of
interest. No signal was observed with prior application of
nitrocellulose, PVDF membranes, or C8 membranes with and without washing. Such surfaces sometimes have higher laser inten sity
thresholds for desorption of ions (12).
The dissociation of viral proteins have historically been
accomplished with urea (13, 14), acetic acid (15) or detergents ( 16 ,
17). Careful selection of matrix additives is necessary due to signal
suppression caused by the acidity /basicity, crystallization, and
desorption properties of the additives (12, 18).
Figure 2 demonstrates differences observed in matrix-
assisted laser desorption ionization spectra of semi-purified
preparations of a MS2 culture, which independently had acetic a n d
citric acid added to the solution. Citric acid yielded better mas s
accuracy, and mass resolution, but more doubly charged ions with
approximately the same laser intensity. Citric acid has three acidic
protons: one with a pKa lower than the single acidic proton of acetic
acid, and another equal to the acidic proton of acetic acid. S odium
citrate has been shown to enhance MALDI protein spectra from
buffered protein solutions laden with salts (19, 20).
Spectra of crude MS2 cultures did not require higher laser
intensity to observe the coat protein molecular ion; however, th e
resolution was poorer than spectra obtained from semi-purified
preparations (Figure 3). Conservation of the coat protein sequence means that mass difference from the calculated molecular weight
value of 13729 Da is due to natriation or kalionation. Spectra were
obtained with several matrices; however, spectral quality varied from
sample to sample of the crude phage solution. In addition,
phosphatidylethanolamine from the host E. coli cell walls were
observed with certain MALDI matrices.
EXAMPLE 6
Detection of Tobacco Mosaic Virus
The desorption of the tobacco mosaic virus from a tobacco
leaf presented the challenge of a host that could potentially inhibit
desorption of the protein of interest with the MALDI matrix, and that
contains an excess of molecules that could suppress MALDI detection.
Despite these complications, Figure 4 demonstrates the detection of
the tobacco mosaic virus directly from a leaf and a leaf extract
sample. The extract provided more intense (i.e. as much as lOx ion
current) detection of the TMV virus compared to direct detection
from a leaf piece. On the basis of the published complete nucleotide
sequence of the genomic RNA of the U2 strain of TMV, the expected
mass for the coat protein is 17,459 Da (21). The mass difference ma y
be attributed to mutations or salt adducts. Table 1 demonstrates th e
mass accuracy from a MALDI-TOF instrument, to which the
manufacturer attests a 0.1% mass accuracy from standards. The
addition of citric acid to infected leaf pieces provided more facile
detection of TMV than acetic acid. Dissociation of TMV coat proteins
has been associated with the disruption of carboxylate groups a t
subunit interfaces (22).
TABLE 1
Molecular Masses for Viral Proteins Measured without Isolation
Number of expected capsid Molecular masses Mass Phage or virus protein (molecules/virion) expected observed3 accuracy fm /z ) (m l?. ) i___
MS2 bacteriophage 180 13729 13784 ± 6b 0.40 Tobacco mosaic virus 2130 17461 17464 ± 29 0.02
Venezuelan equine encephalitis 240 30941 31225 ±105 0.92
"average molecular mass; n EXAMPLE 7
Detection of Venezuelan Equine Encephalitis Virus.
From the semi-purified preparation of Venezuelan Equine
Encephalitis, Figure 5 displays the mass spectrum of the nucleocapsid
protein and an indication of the less glycosylated glycoprotein of th e
two transmembrane glycoproteins (El and E2). This virus sample i s
representative of a biological virus preparation, which contains
chemicals known to degrade matrix-assisted laser desorption
ionization spectra. Maximum laser intensity was needed to observe
the VEE capsid protein. While the capsid protein peak is clearly
visible at m/z 31220, the peak associated with the El glycoprotein a t
m/z 49950 is observed at a 2: 1 signal to noise ratio. Peak
suppression in UV-MALDI analysis of glycoproteins is a frequent
encountered problem due to properties of the sugar moiety.
Discussion
The present invention demonstrates that UV-MALDI can
be used to rapidly detect characteristic proteins of viruses an d
bacteriophages. Without pre-concentration and little or n o
purification, bacteriophage MS2, tobacco mosaic virus, an d Venezuelan equine encephalitis virus have been detected from a
variety of biological media within 3 minutes. Certain matrices an d
additives increase the probability of observing viral proteins ;
however, this does not limit the usefulness of this technique.
While MALDI mass spectrometry has been gaining
popularity as an analytical technique for a range of pure compounds ,
application of the MALDI mass spectrometry to samples in biological
media will expand the utilization of this technique. The concepts
applied in the present invention may be utilized for the rapid
screening of more complex viruses that contain a diverse number of
proteins .
The following references are cited herein.
( 1 ) Ember, L. R. C & E News 1996.
(2) Karas, M., et al, Anal. Chem. 1988, 60: 2299-2301.
(3 ) Jespersen, S., et al., J. Rapid Commun. Mass Spectrom. 1994, 8 :
58 1 -584.
(4) Beavis, R., et al, Proc. Natl. Acad. Sci., USA 1990, 87: 6873-6877.
(5 ) C. Petersen, J., et al., J. Virology 1974, 14: 740-744.
(6) Kinney, R., et al., Virology 1989, 170: 19-30.
(7 ) Grieder, F., et al., Virology 1995, 206: 994-1006. ( 8 ) Despeyroux, D., et al., J. Rapid Commun. Mass Spectrom. 1 996 ,
10: 937-941.
(9) Davis, J., et al, J. Mol. Biol. 1963, 6: 203-207.
( 10) Walkey, D. Applied Plant Virology; John Wiley & Sons, Inc.: New
York, 1985.
( 1 1 Kussman, M., et al, J. Mass Spectrom. 1997, 32: 593-601.
( 12 Worrall, T. A., et al., Anal. Chem. 1998, 70: 750-756.
( 13 Buzzell, A. J. Am. Chem. Soc. 1960, 82: 1636-1641.
( 14 Blowers, L. E., et al., J. Gen. Virol. 1982, 61 : 137-141.
( 15 Fraenkel-Conrat, H. Virology 1957, 4: 1-4.
( 16 Ohno, T., et al.,Virology 1977, 76: 429-432.
( 17 Wilson, T. M., et al., FEBS Letters 1976, 64: 285-289.
( 1 8 Bornsen, K., et al., Rapid Commun. Mass Spectrom. 1997, 1 1 :
603 609.
( 19 Bergman, A., et al., FEBS letters 1996, 397: 45-49.
(20 Walker, K. L., et al., Anal. Chem. 1995, 67: 4197-4204.
(21 Solis, I., et al., Virology 1990, 177: 553-558.
(22 Culver, J. N., et al., Virology 1995, 206: 724-730.
Any patents or publications mentioned in this
specification are indicative of the levels of those skilled in the art to which the invention pertains. These patents and publications are
herein incorporated by reference to the same extent as if each
individual publication was specifically and individually indicated to
be incorporated by reference.
One skilled in the art will readily appreciate that th e
present invention is well adapted to carry out the objects and obtain
the ends and advantages mentioned, as well as those inherent therein .
The present examples along with the methods, procedures ,
treatments, molecules, and specific compounds described herein are
presently representative of preferred embodiments, are exemplary ,
and are not intended as limitations on the scope of the invention.
Changes therein and other uses will occur to those skilled in the art
which are encompassed within the spirit of the invention as defined
by the scope of the claims.

Claims

WHAT IS CLAIMED IS:
1 . A method of detecting viral proteins from a complex
environment, comprising the steps of:
preparing a crude sample of said environment;
mixing said sample with an organic acid;
detecting viral proteins by utilizing mass spectrometry to
said sample.
2. The method of claim 1 , wherein said viral proteins
are structural proteins.
3. The method of claim 2, wherein said viral protein is
a capsid protein.
4. The method of claim 1 , wherein said crude sample is
selected from the group consisting of semi-purified and non-purified
preparations .
5. The method of claim 1 , wherein said organic acid is
selected from the group consisting of acetic acid and citric acid.
6. The method of claim 1 , wherein said organic acid is
premixed with the mass spectrometry matrix.
7. The method of claim 1 , wherein said detection is
accomplished in less than 3 minutes.
8. The method of claim 1 , wherein a femtomolar
concentration of said viral protein is detected.
9. The method of claim 1 , wherein said protein
detected is a bacteriophage protein.
10. The method of claim 1 , wherein said mas s
spectrometry is selected from the group consisting of fast atom
bombardment mass spectrometry, plasma desorption mas s
spectrometry, laser desorption mass spectrometry, matrix-assisted
laser desorption ionization time-of-flight mass spectrometry an d
electrospray mass spectrometry.
PCT/US1999/010658 1998-05-14 1999-05-14 Viral characterization by direct detection of capsid proteins WO1999058727A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU39907/99A AU3990799A (en) 1998-05-14 1999-05-14 Viral characterization by direct detection of capsid proteins

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8538998P 1998-05-14 1998-05-14
US60/085,389 1998-05-14
US09/120,861 US6037118A (en) 1998-05-14 1998-07-22 Viral characterization by direct detection of capsid proteins
US09/120,861 1998-07-22

Publications (1)

Publication Number Publication Date
WO1999058727A1 true WO1999058727A1 (en) 1999-11-18

Family

ID=26772662

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/010658 WO1999058727A1 (en) 1998-05-14 1999-05-14 Viral characterization by direct detection of capsid proteins

Country Status (3)

Country Link
US (1) US6037118A (en)
AU (1) AU3990799A (en)
WO (1) WO1999058727A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680203B2 (en) 2000-07-10 2004-01-20 Esperion Therapeutics, Inc. Fourier transform mass spectrometry of complex biological samples
JP2010088456A (en) * 2002-04-12 2010-04-22 Colorado School Of Mines Method for detecting low concentration of target bacterium that uses phage to infect target bacterial cell
WO2011067516A1 (en) 2009-12-03 2011-06-09 Assistance Publique - Hopitaux De Marseille Method for quick identification of viruses by means of mass spectrometry
CN104007211A (en) * 2014-06-13 2014-08-27 江南大学 Method for extracting plant viruses from plant tissue and authenticating plant viruses through MALDI-TOF-MS
EP3138623A1 (en) * 2008-01-15 2017-03-08 Agena Bioscience, Inc. Compositions and processes for improved mass spectrometry analysis
US10204771B2 (en) 2013-03-13 2019-02-12 Agena Bioscience, Inc. Preparation enhancements and methods of use for MALDI mass spectrometry

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020192676A1 (en) * 2001-06-18 2002-12-19 Madonna Angelo J. Method for determining if a type of bacteria is present in a mixture
US20050003346A1 (en) * 2002-04-12 2005-01-06 Colorado School Of Mines Apparatus and method for detecting microscopic living organisms using bacteriophage
US8216780B2 (en) * 2002-04-12 2012-07-10 Microphage (Tm) Incorporated Method for enhanced sensitivity in bacteriophage-based diagnostic assays
WO2006105504A1 (en) * 2005-03-31 2006-10-05 Microphage Incorporated Apparatus and method for detecting microorganisms using flagged bacteriophage
US20110097702A1 (en) * 2005-03-31 2011-04-28 Voorhees Kent J Methods and compositions for in situ detection of microorganisms on a surface
US20080262972A1 (en) * 2007-04-20 2008-10-23 Blake Patrick J Order confirmation devices, systems, and methods
CA2690809A1 (en) 2007-06-15 2008-12-24 Microphage Incorporated Method of detection of microorganisms with enhanced bacteriophage amplification
US8697434B2 (en) * 2008-01-11 2014-04-15 Colorado School Of Mines Detection of phage amplification by SERS nanoparticles
US9441204B2 (en) * 2008-04-03 2016-09-13 Colorado School Of Mines Compositions and methods for detecting Yersinia pestis bacteria
US8704169B2 (en) 2011-10-11 2014-04-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Direct impact ionization (DII) mass spectrometry

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KRISHNAMURTHY T., ET AL.: "BIOMOLECULES AND MASS SPECTROMETRY.", JOURNAL OF NATURAL TOXINS, COLLINS, CO, US, vol. 06., no. 02., 1 June 1997 (1997-06-01), US, pages 121 - 162., XP002921538, ISSN: 1058-8108 *
SIUZDAK G.: "PROBING VIRUSES WITH MASS SPECTROMETRY.", JOURNAL OF MASS SPECTROMETRY., WILEY, CHICHESTER., GB, vol. 33., no. 03., 1 March 1998 (1998-03-01), GB, pages 203 - 211., XP002921539, ISSN: 1076-5174, DOI: 10.1002/(SICI)1096-9888(199803)33:3<203::AID-JMS653>3.0.CO;2-Q *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680203B2 (en) 2000-07-10 2004-01-20 Esperion Therapeutics, Inc. Fourier transform mass spectrometry of complex biological samples
JP2010088456A (en) * 2002-04-12 2010-04-22 Colorado School Of Mines Method for detecting low concentration of target bacterium that uses phage to infect target bacterial cell
EP3138623A1 (en) * 2008-01-15 2017-03-08 Agena Bioscience, Inc. Compositions and processes for improved mass spectrometry analysis
US9873912B2 (en) 2008-01-15 2018-01-23 Agena Bioscience, Inc. Compositions and processes for improved mass spectrometry analysis
US10329612B2 (en) 2008-01-15 2019-06-25 Agena Bioscience, Inc. Compositions and processes for improved mass spectrometry analysis
WO2011067516A1 (en) 2009-12-03 2011-06-09 Assistance Publique - Hopitaux De Marseille Method for quick identification of viruses by means of mass spectrometry
FR2953530A1 (en) * 2009-12-03 2011-06-10 Assist Publ Hopitaux Marseille METHOD FOR RAPID IDENTIFICATION OF VIRUSES BY MASS SPECTROMETRY
US10204771B2 (en) 2013-03-13 2019-02-12 Agena Bioscience, Inc. Preparation enhancements and methods of use for MALDI mass spectrometry
CN104007211A (en) * 2014-06-13 2014-08-27 江南大学 Method for extracting plant viruses from plant tissue and authenticating plant viruses through MALDI-TOF-MS

Also Published As

Publication number Publication date
AU3990799A (en) 1999-11-29
US6037118A (en) 2000-03-14

Similar Documents

Publication Publication Date Title
US6037118A (en) Viral characterization by direct detection of capsid proteins
US5965358A (en) Method for assessing the relative purity of viral gene transfer vector stocks
Larsen et al. Phospho‐proteomics: Evaluation of the use of enzymatic de‐phosphorylation and differential mass spectrometric peptide mass mapping for site specific phosphorylation assignment in proteins separated by gel electrophoresis
Thomas et al. Viral characterization by direct analysis of capsid proteins
Sobott et al. The flight of macromolecular complexes in a mass spectrometer
Van Duijn Current limitations in native mass spectrometry based structural biology
He et al. Theoretical and experimental prospects for protein identification based solely on accurate mass measurement
Gross et al. Matrix-assisted laser desorption/ionisation–mass spectrometry applied to biological macromolecules
Strupat Molecular weight determination of peptides and proteins by ESI and MALDI
Chong et al. Rapid profiling of E. coli proteins up to 500 kDa from whole cell lysates using matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry
Vaidyanathan et al. Sample preparation in matrix‐assisted laser desorption/ionization mass spectrometry of whole bacterial cells and the detection of high mass (> 20 kDa) proteins
Dycka et al. Rapid and efficient protein enzymatic digestion: an experimental comparison
CN109937363B (en) Mass spectrometry method and kit for identifying microorganisms
Dalluge Mass spectrometry for direct determination of proteins in cells: applications in biotechnology and microbiology
Carr et al. Overview of peptide and protein analysis by mass spectrometry
Wenschuh et al. The ease of peptide detection by matrix‐assisted laser desorption/ionization mass spectrometry: the effect of secondary structure on signal intensity
Horká et al. Capillary and gel electromigration techniques and MALDI-TOF MS–Suitable tools for identification of filamentous fungi
JP2019138810A (en) Microorganism analysis method
Allmaier et al. Accurate determination of the molecular weight of the major surface layer protein isolated from Clostridium thermosaccharolyticum by time-of-flight mass spectrometry
Sanglier et al. Electrospray ionization mass spectrometry analysis revealed a∼ 310 kDa noncovalent hexamer of HPr kinase/phosphatase from Bacillus subtilis
Colgrave Primary structural analysis of cyclotides
Liu et al. Proteomic study of recombinant adenovirus 5 encoding human p53 by matrix-assisted laser desorption/ionization mass spectrometry in combination with database search
CN114902051A (en) Methods for analyzing AAV capsid proteins
Haag et al. Monitoring of immune response by blood serum profiling using matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry
Christofakis et al. LC–MS/MS techniques for food allergen testing

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase